Clinical trial
Effects of Pramlintide on Endogenous Production of VLDL-Triglyceride and Glucose in the Post Prandial State in Type 2 Diabetes Mellitus
NCT00732147 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Pramlintide on Endogenous Production of VLDL-Triglyceride and Glucose in the Post Prandial State in Type 2 Diabetes Mellitus
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- April 30, 2009
- Completion date
- April 30, 2011
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes